Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Study to Describe Carfilzomib Use on Patients With Relapsed Multiple Myeloma in France in the Context of Carfilzomib Nominative Expanded Access and Compassionate Use

NCT04811508 is registered in ClinicalTrials.gov with Centre Hospitalier le Mans as lead sponsor.

NCT NCT04811508
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04811508 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Study to Describe Carfilzomib Use on Patients With Relapsed Multiple Myeloma in France in the Context of Carfilzomib Nominative Expanded Access and Compassionate Use
Lead sponsor
Centre Hospitalier le Mans
Phase
Observational
Overall status
Completed
Start date
August 4, 2020
Completion date
December 31, 2021
Enrollment
172 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

relapsed multiple myeloma